Eulogy’s Post

🔥 Revolutionising Care for Inflammatory Conditions: A 360° Approach 🏥🔬 Join us for an insightful discussion with Nader Alaghband (Ampersand Health) and Jo Peddhinti as we explore the cutting-edge innovations reshaping treatment for inflammatory disorders! 🔍 What we'll uncover: 📱 Digital innovations transforming treatments and potential cures 🚀 Key market trends in therapies, diagnostics, and tech solutions 🧠 Is the field ready for these innovative therapies? 🖥️ The game-changing role of advanced imaging and wearables Don't miss this chance to dive deep into the future of personalised, tech-driven healthcare! Register Now ➡️ https://lnkd.in/eCv5t_5V #InflammatoryCare #HealthTechInnovation #PersonalisedMedicine #HLTH Who's joining us to revolutionise inflammatory condition care? Let's connect! 👇

𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐒𝐜𝐚𝐥𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐆𝐥𝐨𝐛𝐚𝐥 𝐒𝐢𝐳𝐞, 𝐒𝐡𝐚𝐫𝐞 & 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟑𝟒 ▶𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐟𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅: https://lnkd.in/dHdNgSwm The Medical Scales market, valued at USD 455.4 billion in 2020, is anticipated to grow to USD 737.3 billion by 2030, achieving a CAGR of 5.50% over the forecast period. These scales are essential tools in medical settings, providing critical weight measurements that inform treatment decisions, dosage adjustments, and assessments of patient health such as fluid retention, malnutrition, or obesity. They play a crucial role in monitoring health trends by detecting even slight weight fluctuations that may signal underlying health issues. The market is poised for steady growth, driven by ongoing healthcare needs and advancements in medical technology supporting accurate patient care. 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: ▶𝐁𝐲 𝐒𝐜𝐚𝐥𝐞 𝐓𝐲𝐩𝐞: Regular Scales, Wheelchair Scales, Infant and Baby Scales, Others. ▶𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬: Hospital, Household, Dialysis Center, Nursing Center, Others. ▶𝐁𝐲 𝐍𝐚𝐭𝐮𝐫𝐞: Analog, Digital. ▶𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧: North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA). 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐜𝐨𝐯𝐞𝐫𝐞𝐝:          Algen Biotechnologies, Detecto Scale, Doran Scales, Inc., Natus Medical Incorporated, Pelstar LLC, seca – precision for health, SR Instruments, Inc., TANITA Europe B.V. - Leading Health Insights, Wedderburn, Welch Allyn, Natus Medical Incorporated, myweightclinic.com, Marsden Group. #MedicalScales #HealthcareTech #DigitalHealth #PrecisionMedicine #MedicalDevices #HealthTech #WeightManagement #HealthMonitoring #SmartScales #PatientCare #Telehealth #HealthAnalytics #BodyComposition #RemoteMonitoring #ClinicalScales #IoTHealth #WearableTech #FitnessTracking #Bioimpedance #HealthData

【NEWS RELEASE】 「国立大学院における弊社販売予定商品を活用した研究」開始のお知らせ   この度、株式会社エウクラシア（本社：東京都港区港南2丁目12番23号明産高浜ビル6階、代表取締役社長　小島健彰）は、「放送大学学園大学院 生活健康科学プログラム所属研究室」における、「弊社販売予定商品を活用した研究（弊社社内研究倫理委員会受付番号EUR-CT20240426-01）」支援を、今月2024/9より開始することなりましたので、ここにお知らせいたします。尚、今回この研究に活用する商品は、弊社の協業会社であるLifePlus社（本社：1625 The Alameda, Suite 406 San Jose, CA95126, CEO Alodeep Sanyal,PhD）が現在提供、企画する「非侵襲型リアルタイムモニタリングデバイス（米国商品名：Lifeleaf™️）」を利用致します。   なお当研究支援の詳細につきましては、今後追ってお伝えさせていただきます。   【LifePlus社】 慢性疾患を抱える人々の日々の健康管理に対する「Deep Health technology」を開発するシリコンバレーのスタートアップ企業　 https://lnkd.in/gxRUdxW [NEWS RELEASE] Commencement of Research Using Our Upcoming Product at a National Graduate University We, Eucrasia K.K. (Headquarters: 6th Floor, Meisan Takahama Building, 2-12-23 Konan, Minato-ku, Tokyo; CEO: Kensho Kojima), are pleased to announce that we will begin supporting research utilising our upcoming product at the "Laboratory of Health and Nutrition Sciences Programme, The Open University of Japan Graduate School" from September 2024. This research (Internal Ethics Committee Reference Number: EUR-CT20240426-01) will employ our soon-to-be-launched product. The product used in this research is the "Non-invasive Real-time Monitoring Device" (US product name: Lifeleaf™️), currently provided and developed by our partner company, LifePlus Inc. (Headquarters: 1625 The Alameda, Suite 406, San Jose, CA 95126, USA; CEO: Alodeep Sanyal, PhD). Further details regarding this research support will be communicated in due course. [About LifePlus Inc.] LifePlus is a Silicon Valley start-up developing "Deep Health technology" for the daily health management of individuals with chronic conditions.

Check out these NZ healthtech innovators!

The growing importance and future of Behavioural Science in HealthTech and Digital Health https://lnkd.in/epGjfq8J The Future of Behaviour Science in HealthTech Just-in-Time Adaptive Interventions (JITAIs): Imagine receiving a craving suppressant notification right before you walk past a fast-food joint, or a nudge to meditate when your smartwatch detects rising stress. JITAIs deliver the right support at the right moment, maximising impact. Micro-randomised Control Trials (MRTs): These research studies help fine-tune JITAIs by testing different intervention components in real-time. Like a scientist testing pizza combinations, MRTs identify the most effective elements for specific situations. Hyper-personalisation: The future lies in interventions tailored to individual needs and preferences. Imagine AI-powered health tools that analyse user data and recommend personalised strategies in real-time. Focus on preventative care: Behavioural science can revolutionise preventative care by designing apps that encourage healthy habits. Sleep trackers that nudge you towards a consistent sleep schedule are a prime example. Nelson Advisors work with Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value.   > HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk   > HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb   > HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk   > Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/eeX9Bcwa #HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy https://lnkd.in/epGjfq8J

🌐 Bioimpedance Analyzers Market: Powering Precision in Body Composition Analysis! 🌐 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐯𝐞 𝐏𝐃𝐅: https://lnkd.in/d__kaXyh The global Bioimpedance Analyzers Market is making waves, with applications driving innovation in Segmental Body Measurement and Whole Body Measurement. 🎯 Whether it's segmental analysis providing detailed insights into specific body parts or whole-body assessment offering comprehensive health data, these devices are revolutionizing healthcare and fitness! Key benefits: 📈 Accurate body composition analysis 🏃♂️ Enhanced patient outcomes in medical diagnostics & sports science 💡 Efficient tools for personalized health monitoring The global bioimpedance analyzers market in terms of revenue was estimated to be worth $564 million in 2023 and is poised to reach $927 million by 2028, growing at a CAGR of 10.4% Discover how this market is shaping the future of health tech! 🚀 #BioimpedanceAnalyzers #BodyComposition #HealthcareTech #SegmentalMeasurement #WholeBodyMeasurement #MedicalDevices #HealthInnovation #FitnessTech

Would you agree if I say #ConnectedHealth is revolutionizing #healthcare accessibility, boosting the quality of life, and lightening the load on health networks? Let's discuss how the #healthcare industry has made significant strides in recent years. While Apple Watch, Fitbit may dominate the conversations in public domain, the real connected health work spans from diagnostics to therapy management to patient service. Specifically in chronic disease areas - diabetes, renal, cardiovascular, pulmonary, etc. the connected health is making tangible difference for patients.   @Capgemini's latest report compares and contrasts statistics from their previous editions and uncovers how we can advance our technical prowess, embrace #Digital, and forge partnerships to drive tangible outcomes and value. Here's the link to access the full report: https://bit.ly/3VPEXUc   #HLTH #HLTHEurope Life Sciences

Even the most conservative projections estimate that the US Digital Biomarker market will grow at a CAGR of 22.86% to $8.59 billion by 2029. It stood at $2.49 billion at the end of 2023! What does it mean for you? As a Healthcare Provider, how can you best ride this trend? And what are the implementation challenges that you should know about? Here's a quick read answering all your questions - https://lnkd.in/dzwbsmpz #digitalhealth #healthtech #continuouscare

𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $549.7 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2028 Get a Free Sample Report: https://lnkd.in/dHh8GNiN The global digital health market is projected to reach $549.7 billion by 2028, growing at a CAGR of 25.0%! Key drivers: • Telemedicine expansion 🏥 • Patient empowerment 💪 • Health tech investments 💰 Hot areas: • Telehealthcare 📱 • Chronic disease management 🫀 • Hardware solutions 🖥️ Asia Pacific leads in growth potential. Are you ready for the digital health revolution? 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Koninklijke Philips N.V. (Netherlands), Medtronic, GE HealthCare, Abbott, OMRON Corporation (Japan), Fitbit (now part of Google), Johnson & Johnson, Siemens Healthineers, Masimo, Apple, Merative, AT & T, Inc. (US), Veradigm LLC (US), Noom, Inc. (US), Teladoc Health, Inc. (US), Omada Health Inc. (US), Dexcom, Inc. (US), Biotricity Inc., iHealth Labs Inc (US), my mhealth Limited (UK), athenahealth (US), eClinicalWorks (US), AirStrip Technologies, Inc (US), AdvancedMD, Inc. (US) and Qardio, Inc. (US) Other Companies that are Operating in this Market Globally: Edifecs Cygnus Professionals Inc.      iRhythm Technologies, Inc.  GoHealth iOrbit Digital Technologies OSF HealthCare Loblaw Digital Sharecare HITLAB ObvioHealth LifeScan TechBlocks MedTech Innovator Mindbloom DarioHealth Wysa Wheel Lunit Cancer Screening Ellipsis Health Artera Vim SpectraMedix Owlet Baby Care PatientPoint® Redox #DigitalHealth #HealthTech #FutureOfHealthcare

𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 (𝐃𝐓𝐱) 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐓𝐡𝐫𝐨𝐮𝐠𝐡 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐑𝐄𝐄 𝐒𝐚𝐦𝐩𝐥𝐞: https://lnkd.in/g3djBEhG The 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 (𝐃𝐓𝐱) 𝐌𝐚𝐫𝐤𝐞𝐭 is revolutionizing the healthcare industry by delivering evidence-based therapeutic interventions through software and digital platforms. These innovations target a wide range of diseases, offering personalized care while improving patient outcomes and reducing costs. 𝐀𝐬 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐠𝐫𝐨𝐰𝐬, 𝐤𝐞𝐲 𝐭𝐫𝐞𝐧𝐝𝐬 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐭𝐡𝐢𝐬 𝐞𝐱𝐩𝐚𝐧𝐬𝐢𝐨𝐧 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: 1.     Increasing prevalence of chronic diseases. 2.     Rising demand for cost-effective healthcare solutions. 3.     Integration of AI and machine learning in therapeutic programs. 4.     Regulatory support and reimbursement for digital health solutions. 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: The digital therapeutics (DTx) market comprises various market key players such as: ·       Omada Health ·       Welldoc ·       Fitbit health ·       Canary Health ·       Lupin ·       Noom ·       CureApp, Inc. ·       Propeller Health 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭: https://lnkd.in/g7ZWFhnw With advancements in technology and growing patient acceptance, DTx is poised to reshape healthcare delivery by enabling more proactive, real-time, and efficient care. #digitaltherapeutics #healthcareinnovation #dtx #healthtech #futureofhealthcare #digitalhealth #marketresearch #markettrends #marketanalysis